A citation-based method for searching scientific literature

Kathryn L Terry, Helena Schock, Renée T Fortner, Anika Hüsing, Raina N Fichorova, Hidemi S Yamamoto, Allison F Vitonis, Theron Johnson, Kim Overvad, Anne Tjønneland, Marie-Christine Boutron-Ruault, Sylvie Mesrine, Gianluca Severi, Laure Dossus, Sabina Rinaldi, Heiner Boeing, Vassiliki Benetou, Pagona Lagiou, Antonia Trichopoulou, Vittorio Krogh, Elisabetta Kuhn, Salvatore Panico, H Bas Bueno-de-Mesquita, N Charlotte Onland-Moret, Petra H Peeters, Inger Torhild Gram, Elisabete Weiderpass, Eric J Duell, Maria-Jose Sanchez, Eva Ardanaz, Nerea Etxezarreta, Carmen Navarro, Annika Idahl, Eva Lundin, Karin Jirström, Jonas Manjer, Nicholas J Wareham, Kay-Tee Khaw, Karl Smith Byrne, Ruth C Travis, Marc J Gunter, Melissa A Merritt, Elio Riboli, Daniel W Cramer, Rudolf Kaaks. Clin Cancer Res 2016
Times Cited: 46







List of co-cited articles
268 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
491
50

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Daniel W Cramer, Robert C Bast, Christine D Berg, Eleftherios P Diamandis, Andrew K Godwin, Patricia Hartge, Anna E Lokshin, Karen H Lu, Martin W McIntosh, Gil Mor,[...]. Cancer Prev Res (Phila) 2011
196
30

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
731
23

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.
Karen H Lu, Steven Skates, Mary A Hernandez, Deepak Bedi, Therese Bevers, Leroy Leeds, Richard Moore, Cornelius Granai, Steven Harris, William Newland,[...]. Cancer 2013
74
21

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
Saundra S Buys, Edward Partridge, Mark H Greene, Philip C Prorok, Douglas Reding, Thomas L Riley, Patricia Hartge, Richard M Fagerstrom, Lawrence R Ragard, David Chia,[...]. Am J Obstet Gynecol 2005
214
17

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
Wei-Lei Yang, Aleksandra Gentry-Maharaj, Archana Simmons, Andy Ryan, Evangelia Ourania Fourkala, Zhen Lu, Keith A Baggerly, Yang Zhao, Karen H Lu, David Bowtell,[...]. Clin Cancer Res 2017
30
26

Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2016
15


Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
Usha Menon, Andy Ryan, Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Anne Dawnay, Mariam Habib, Sophia Apostolidou, Naveena Singh, Elizabeth Benjamin, Matthew Burnell,[...]. J Clin Oncol 2015
117
15

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
R C Bast, T L Klug, E St John, E Jenison, J M Niloff, H Lazarus, R S Berkowitz, T Leavitt, C T Griffiths, L Parker,[...]. N Engl J Med 1983
15

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.
Garnet L Anderson, Martin McIntosh, Lieling Wu, Matt Barnett, Gary Goodman, Jason D Thorpe, Lindsay Bergan, Mark D Thornquist, Nathalie Scholler, Nam Kim,[...]. J Natl Cancer Inst 2010
141
13

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.
T Van Gorp, I Cadron, E Despierre, A Daemen, K Leunen, F Amant, D Timmerman, B De Moor, I Vergote. Br J Cancer 2011
198
13

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G Lynch, Mohamed Riad, Raghwa Sharma, Colin Stewart, Sian Fereday, Carlos Caldas, Anna Defazio,[...]. J Pathol 2010
446
13

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.
E Riboli, K J Hunt, N Slimani, P Ferrari, T Norat, M Fahey, U R Charrondière, B Hémon, C Casagrande, J Vignat,[...]. Public Health Nutr 2002
13

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Richard G Moore, Amy K Brown, M Craig Miller, Steven Skates, W Jeffrey Allard, Thorsten Verch, Margaret Steinhoff, Geralyn Messerlian, Paul DiSilvestro, C O Granai,[...]. Gynecol Oncol 2008
422
13

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
Richard G Moore, D Scott McMeekin, Amy K Brown, Paul DiSilvestro, M Craig Miller, W Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C Bast, Steven J Skates. Gynecol Oncol 2009
477
13

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Aarti Sharma, Sara Lewis, Susan Davies, Susan Philpott, Alberto Lopes,[...]. Lancet Oncol 2009
503
13

Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.
Archana R Simmons, Charlotte H Clarke, Donna B Badgwell, Zhen Lu, Lori J Sokoll, Karen H Lu, Zhen Zhang, Robert C Bast, Steven J Skates. Int J Gynecol Cancer 2016
19
31

Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
Renée Turzanski Fortner, Antje Damms-Machado, Rudolf Kaaks. Gynecol Oncol 2017
35
17

Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Joshua D Cohen, Lu Li, Yuxuan Wang, Christopher Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A Javed, Fay Wong, Austin Mattox,[...]. Science 2018
967
13

Detection of circulating tumor DNA in early- and late-stage human malignancies.
Chetan Bettegowda, Mark Sausen, Rebecca J Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R Bartlett, Hao Wang, Brandon Luber, Rhoda M Alani,[...]. Sci Transl Med 2014
10

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.
Richard G Moore, M Craig Miller, Paul Disilvestro, Lisa M Landrum, Walter Gajewski, John J Ball, Steven J Skates. Obstet Gynecol 2011
154
10

Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Koji Nakamura, Kenjiro Sawada, Akihiko Yoshimura, Yasuto Kinose, Erika Nakatsuka, Tadashi Kimura. Mol Cancer 2016
96
10

Development of a multimarker assay for early detection of ovarian cancer.
Zoya Yurkovetsky, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks, Andrew Godwin, Elieser Gorelik, Ian Jacobs,[...]. J Clin Oncol 2010
177
10


MUC16: molecular analysis and its functional implications in benign and malignant conditions.
Dhanya Haridas, Moorthy P Ponnusamy, Seema Chugh, Imayavaramban Lakshmanan, Parthasarathy Seshacharyulu, Surinder K Batra. FASEB J 2014
56
10

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter, Jeffrey A Ledbetter, Michèl Schummer, Martin McIntosh, Charles Drescher, Nicole Urban, Karl Erik Hellström. Cancer Res 2003
470
10

Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Isaac Kinde, Chetan Bettegowda, Yuxuan Wang, Jian Wu, Nishant Agrawal, Ie-Ming Shih, Robert Kurman, Fanny Dao, Douglas A Levine, Robert Giuntoli,[...]. Sci Transl Med 2013
189
10


Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
Robert L Coleman, Thomas J Herzog, Daniel W Chan, Donald G Munroe, Todd C Pappas, Alan Smith, Zhen Zhang, Judith Wolf. Am J Obstet Gynecol 2016
49
10

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
10

A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.
Chanhee Han, Stefania Bellone, Eric R Siegel, Gary Altwerger, Gulden Menderes, Elena Bonazzoli, Tomomi Egawa-Takata, Francesca Pettinella, Anna Bianchi, Francesco Riccio,[...]. Gynecol Oncol 2018
28
17

Liquid biopsies: genotyping circulating tumor DNA.
Luis A Diaz, Alberto Bardelli. J Clin Oncol 2014
8

Factors influencing serum CA125II levels in healthy postmenopausal women.
D K Pauler, U Menon, M McIntosh, H L Symecko, S J Skates, I J Jacobs. Cancer Epidemiol Biomarkers Prev 2001
87
8

CA 125 levels in menopausal women.
C Westhoff, E Gollub, J Patel, H Rivera, R Bast. Obstet Gynecol 1990
22
18

The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
Christine C Johnson, Bruce Kessel, Thomas L Riley, Lawrence R Ragard, Craig R Williams, Jian-Lun Xu, Saundra S Buys. Gynecol Oncol 2008
67
8

p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.
Karen S Anderson, Jessica Wong, Allison Vitonis, Christopher P Crum, Patrick M Sluss, Joshua Labaer, Daniel Cramer. Cancer Epidemiol Biomarkers Prev 2010
75
8

Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.
Laura J Havrilesky, Gillian D Sanders, Shalini Kulasingam, Junzo P Chino, Andrew Berchuck, Jeffrey R Marks, Evan R Myers. Cancer 2011
25
16

Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI.
Natalie L Adolphi, Kimberly S Butler, Debbie M Lovato, T E Tessier, Jason E Trujillo, Helen J Hathaway, Danielle L Fegan, Todd C Monson, Tyler E Stevens, Dale L Huber,[...]. Contrast Media Mol Imaging 2012
38
10



Autoantibody signature for the serologic detection of ovarian cancer.
Karen S Anderson, Daniel W Cramer, Sahar Sibani, Garrick Wallstrom, Jessica Wong, Jin Park, Ji Qiu, Allison Vitonis, Joshua LaBaer. J Proteome Res 2015
59
8

Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study.
Elisabeth Maritschnegg, Yuxuan Wang, Nina Pecha, Reinhard Horvat, Els Van Nieuwenhuysen, Ignace Vergote, Florian Heitz, Jalid Sehouli, Isaac Kinde, Luis A Diaz,[...]. J Clin Oncol 2015
43
9


Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
Ruth Perets, Gregory A Wyant, Katherine W Muto, Jonathan G Bijron, Barish B Poole, Kenneth T Chin, Jin Yun H Chen, Anders W Ohman, Corey D Stepule, Soongu Kwak,[...]. Cancer Cell 2013
324
8

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.
B Burford, A Gentry-Maharaj, R Graham, D Allen, J W Pedersen, A S Nudelman, O Blixt, E O Fourkala, D Bueti, A Dawnay,[...]. Br J Cancer 2013
42
9

A randomized study of screening for ovarian cancer: a multicenter study in Japan.
H Kobayashi, Y Yamada, T Sado, M Sakata, S Yoshida, R Kawaguchi, S Kanayama, H Shigetomi, S Haruta, Y Tsuji,[...]. Int J Gynecol Cancer 2008
153
8

Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.
Jian-Xiang Shi, Jie-Jie Qin, Hua Ye, Peng Wang, Kai-Juan Wang, Jian-Ying Zhang. Expert Rev Mol Diagn 2015
24
16

Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer.
Anna E Lokshin, Mathew Winans, Douglas Landsittel, Adele M Marrangoni, Lyudmila Velikokhatnaya, Francesmary Modugno, Brian M Nolen, Elieser Gorelik. Gynecol Oncol 2006
99
8

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.
Richard G Moore, Moune Jabre-Raughley, Amy K Brown, Katina M Robison, M Craig Miller, W Jeffery Allard, Robert J Kurman, Robert C Bast, Steven J Skates. Am J Obstet Gynecol 2010
163
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.